These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 8917631

  • 1. Heregulin induces increase in sensitivity of an erbB-2-overexpressing breast cancer cell type to lysis by lymphokine-activated killer cells.
    Cardillo M, Yankelevich B, Mazumder A, Lupu R.
    Cancer Immunol Immunother; 1996 Sep; 43(1):19-25. PubMed ID: 8917631
    [Abstract] [Full Text] [Related]

  • 2. Interferon-gamma-induced increased sensitivity of HER2/neu-overexpressing tumor cells to lymphokine-activated killer cell lysis: importance of ICAM-1 in binding and post-binding events.
    Fady C, Gardner A, Gera JF, Lichtenstein A.
    Cancer Immunol Immunother; 1993 Oct; 37(5):329-36. PubMed ID: 8104695
    [Abstract] [Full Text] [Related]

  • 3. Resistance of HER2/neu-overexpressing tumor targets to lymphokine-activated-killer-cell-mediated lysis: evidence for deficiency of binding and post-binding events.
    Fady C, Gardner A, Gera JF, Lichtenstein A.
    Cancer Immunol Immunother; 1993 May; 36(5):307-14. PubMed ID: 8097427
    [Abstract] [Full Text] [Related]

  • 4. Interferon-induced increase in sensitivity of ovarian cancer targets to lysis by lymphokine-activated killer cells: selective effects on HER2/neu-overexpressing cells.
    Fady C, Gardner AM, Gera JF, Lichtenstein A.
    Cancer Res; 1992 Feb 15; 52(4):764-9. PubMed ID: 1346583
    [Abstract] [Full Text] [Related]

  • 5. Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis.
    Xu FJ, Stack S, Boyer C, O'Briant K, Whitaker R, Mills GB, Yu YH, Bast RC.
    Clin Cancer Res; 1997 Sep 15; 3(9):1629-34. PubMed ID: 9815853
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1.
    Haustein M, Ramer R, Linnebacher M, Manda K, Hinz B.
    Biochem Pharmacol; 2014 Nov 15; 92(2):312-25. PubMed ID: 25069049
    [Abstract] [Full Text] [Related]

  • 10. Modulation of breast cancer progression and differentiation by the gp30/heregulin [correction of neregulin].
    Staebler A, Sommers C, Mueller SC, Byers S, Thompson EW, Lupu R.
    Breast Cancer Res Treat; 1994 Nov 15; 31(2-3):175-82. PubMed ID: 7881097
    [Abstract] [Full Text] [Related]

  • 11. Membrane-associated lymphotoxin-expressing lymphokine-activated killer cells up-regulate intercellular adhesion molecule-1 expression on target tumor cells in vitro.
    Kimura K, Abe Y, Horiuchi A, Miyake M, Kimura S.
    Cell Immunol; 1995 Aug 15; 164(1):119-25. PubMed ID: 7634343
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Decreased expression of ICAM-1 and its induction by tumor necrosis factor on breast-cancer cells in vitro.
    Budinsky AC, Brodowicz T, Wiltschke C, Czerwenka K, Michl I, Krainer M, Zielinski CC.
    Int J Cancer; 1997 Jun 11; 71(6):1086-90. PubMed ID: 9185715
    [Abstract] [Full Text] [Related]

  • 14. Role of adhesion molecules in lymphokine-activated killer cell killing of bladder cancer cells: further evidence for a third ligand for leucocyte function-associated antigen-1.
    Jackson AM, Alexandrov AB, Prescott S, James K, Chisholm GD.
    Immunology; 1992 Jun 11; 76(2):286-91. PubMed ID: 1353063
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intercellular adhesion molecule-1 expression by bladder cancer cells: functional effects.
    Campbell SC, Tanabe K, Alexander JP, Edinger M, Tubbs RR, Klein EA.
    J Urol; 1994 May 11; 151(5):1385-90. PubMed ID: 7908992
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.